Anette Klinger Selected Research

Anette Klinger Research Topics

11	Neoplasms (Cancer) 12/2021 - 01/2019
3	Multiple Myeloma 04/2022 - 07/2020
3	Leukemia 12/2021 - 07/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2021 - 01/2020
2	Breast Neoplasms (Breast Cancer) 06/2021 - 01/2019
1	Colitis 01/2022
1	Inflammation (Inflammations) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Carcinogenesis 01/2021
1	Neoplasm Metastasis (Metastasis) 10/2020
1	Hepatocellular Carcinoma (Hepatoma) 10/2020
1	Necrosis 07/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2017

5	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 06/2021 - 01/2019
3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 06/2021 - 01/2019
2	chlorothricinIBA 04/2022 - 01/2021
2	Aurora Kinase AIBA 04/2022 - 01/2021
2	resazurinIBA 01/2021 - 07/2020
2	Vitamin K 3 (Menadione)FDA Link 10/2020 - 01/2020
1	NaphthoquinonesIBA 01/2022
1	Dextran SulfateIBA 01/2022
1	moniliforminIBA 12/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2021
1	Eukaryotic Initiation Factor-2 (EIF 2)IBA 11/2021
1	Messenger RNA (mRNA)IBA 11/2021
1	isopetasinIBA 06/2021
1	XenobioticsIBA 06/2021
1	N- (4- ((3- (2- amino- 4- pyrimidinyl)- 2- pyridinyl)oxy)phenyl)- 4- (4- methyl- 2- thienyl)- 1- phthalazinamineIBA 01/2021
1	LigandsIBA 01/2021
1	ZincIBA 01/2021
1	Translationally-Controlled 1 Tumor ProteinIBA 01/2021
1	salvinIBA 10/2020
1	AntioxidantsIBA 10/2020
1	TubulinIBA 10/2020
1	secalonic acidIBA 07/2020
1	Syntex adjuvant formulationIBA 07/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Vitamin K FDA Link 01/2020
1	Phosphotransferases (Kinase)IBA 09/2019
1	multidrug resistance-associated protein 1IBA 01/2019
1	lawsoneIBA 12/2017
1	CateninsIBA 12/2017

4	Therapeutics 12/2021 - 01/2019
4	Drug Therapy (Chemotherapy) 06/2021 - 01/2019